For example, PTK6 has been extensively studied in breast cancers for its pro-oncogenic roles including cell cycle progression [21], angiogenesis [22], anoikis resistance [23] and cellular migration [13], while PTK6 has been shown to work anti-oncogenically in esophageal cancer [24]. The gene discussed is PTK6; the disease is breast cancer.